PD-1 Immune Checkpoint Blockade Promotes Therapeutic Cancer Vaccine to Eradicate Lung Cancer

Clinical development of targeted and immune based anti-cancer therapies

(2019) N. A. Seebacher et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)

(2018) Julie R. Brahmer et al.   Journal for ImmunoTherapy of Cancer

White paper on microbial anti-cancer therapy and prevention

(2018) Neil S. Forbes et al.   Journal for ImmunoTherapy of Cancer

Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies

(2018) Roberta Zappasodi et al.   CANCER CELL

Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine

(2018) Jake R. Conway et al.   Genome Medicine

The next generation of immunotherapy: keeping lung cancer in check

(2017) Ashwin Somasundaram et al.   Journal of Hematology & Oncology

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

(2012) Suzanne L. Topalian et al.   NEW ENGLAND JOURNAL OF MEDICINE

Correction: Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer

(2012) Minu K. Srivastava et al.   PLoS One

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

(2011) Caroline Robert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE